Market cap
$559 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
77.2
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -76.80 | -32.07 | -35.11 |
| EBIT | -- | -- | 8.13 | 2.27 | -0.21 |
| Net Profit | -108.62 | -175.30 | -60.66 | -26.59 | -44.44 |
| EPS | -97.47 | -155.58 | -35.86 | 1.51 | 3.08 |
| Book Value | -- | -- | 32.15 | -11.41 | -7.09 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -31,928.32 | -21,527.74 | -- | -27,235.71 | -5,263.54 |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| -97.22 | -89.77 | -167.26 | -108.01 | -103.34 |
| Return on Capital
| -94.20 | -87.41 | -- | -104.26 | -99.76 |
| Return on Assets
| -83.92 | -77.37 | -79.05 | -90.13 | -90.20 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.04 | 0.03 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
--
|
-104.26
|
-99.76
|
-78.59
|
-75.31
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-167.26
Lower than Peers by 129.66
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
-167.26
|
-108.01
|
-103.34
|
-80.30
|
-76.17
|
|
Peer Median
|
-37.60
|
--
|
--
|
--
|
--
|
ROA
-79.05
Lower than Peers by 35.99
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
-79.05
|
-90.13
|
-90.20
|
-71.42
|
-66.84
|
|
Peer Median
|
-43.06
|
--
|
--
|
--
|
--
|
EBIT Margin
--
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
--
|
-27,235.71
|
-5,263.54
|
-63,285.71
|
-9,714.18
|
|
Peer Median
|
-40.72
|
--
|
--
|
--
|
--
|
Net Margin
--
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
--
|
-27,235.71
|
-5,271.27
|
-63,492.86
|
-9,754.48
|
|
Peer Median
|
-77.79
|
--
|
--
|
--
|
--
|
Revenue Growth
--
--
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
--
|
-0.77
|
11.93
|
-0.90
|
-0.77
|
|
Peer Median
|
256.74
|
--
|
--
|
--
|
--
|
EBIT Growth
8.13
Lower than Peers by 5.92
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
8.13
|
-20.07
|
-7.53
|
31.94
|
-6.55
|
|
Peer Median
|
14.05
|
--
|
--
|
--
|
--
|
Net Profit Growth
-60.66
Lower than Peers by 74.23
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
-60.66
|
-19.89
|
-7.33
|
31.99
|
-7.25
|
|
Peer Median
|
13.57
|
--
|
--
|
--
|
--
|
EPS Growth
-35.86
Lower than Peers by 68.70
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
-35.86
|
0.02
|
0.15
|
0.34
|
-0.07
|
|
Peer Median
|
32.84
|
--
|
--
|
--
|
--
|
Book Value Growth
-60.91
Lower than Peers by 38.39
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
-60.91
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-22.52
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
--
|
0.04
|
0.03
|
0.04
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.03
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
0.03
|
0.02
|
0.02
|
0.01
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
8.98
Higher than Peers by 3.37
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
8.98
|
3.23
|
7.63
|
10.32
|
9.58
|
|
Peer Median
|
5.61
|
--
|
--
|
--
|
--
|
Quick Ratio
8.98
Higher than Peers by 3.46
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
8.98
|
--
|
--
|
--
|
9.80
|
|
Peer Median
|
5.52
|
--
|
--
|
--
|
--
|
Interest Coverage
-5.20
Lower than Peers by 2.62
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
-5.20
|
--
|
--
|
--
|
-0.50
|
|
Peer Median
|
-2.57
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
--
|
521.43
|
69.61
|
--
|
183.58
|
|
Peer Median
|
40.61
|
--
|
--
|
--
|
--
|
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
--
|
0.00
|
0.02
|
0.00
|
0.01
|
|
Peer Median
|
0.10
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
--
|
1,500.13
|
127.13
|
3,208.98
|
584.67
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
--
|
--
|
--
|
-1,917.56
|
-1,063.20
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
--
|
2,521.96
|
228.28
|
326.12
|
330.89
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
--
|
--
|
--
|
965.30
|
-809.43
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
--
|
-7.83
|
-8.37
|
-2.01
|
-1.61
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
77.21
Higher than Peers by 74.37
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
77.21
|
6.84
|
9.88
|
1.72
|
1.79
|
|
Peer Median
|
2.84
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-1.52
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
-1.52
|
-7.27
|
-7.53
|
-0.82
|
-0.68
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
559
Higher than Peers by 557
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Entera Bio - ADR (ENTX)
|
559
|
--
|
--
|
--
|
--
|
|
Peer Median
|
3
|
--
|
--
|
--
|
--
|